Oncology
5,185 studies511 in 7 days2,486 in 30 days
Filters
Latest
5,185 studies
- Neutrophil to lymphocyte ratio (NLR) predicts pathological response to neoadjuvant immunochemotherapy in resectable esophageal cancer: a retrospective study.
- Subtype-associated clinicopathological and tumor immune microenvironment heterogeneity in primary EGFR T790M compound-mutant lung adenocarcinoma: a retrospective cohort study.
- Beyond the blood-brain barrier: amivantamab plus lazertinib in EGFR-mutant non-small cell lung cancer with brain and leptomeningeal metastases.
- Real-world effectiveness of first-line chemoimmunotherapy versus chemotherapy in older adults with extensive-stage small cell lung cancer: an inverse probability treatment weighted analysis
- Lactylation in glioblastoma: mechanisms and therapeutic perspectives
- Research progress on the key cuproptosis regulator FDX1 and its relevance to triple-negative breast cancer
- Mechanisms by which programmed cell death mediates immune evasion and antitumour immunity in oropharyngeal cancer
- Epithelial–mesenchymal plasticity is associated with transcriptional variation in regulated cell death and immune signaling programs in lung adenocarcinoma
- Functional and oncological outcomes after laparoscopic versus open total mesorectal excision for rectal cancer: a propensity score-matched study
- Bladder metastasis from cutaneous melanoma during adjuvant immunotherapy: A case report and literature review
- Protocol for live-cell imaging and analysis of NF-κB localization and target gene transcription in Drosophila S2∗ cells
- Meta-analysis of 990 EBV genomes identifies EBER2 SNP7048 and its interaction with HLA-A*11:01 driving nasopharyngeal carcinoma risk
- HER2 CAR-expressing iPSC-derived iNKT cells exhibit multifaceted immunomodulatory functions beyond direct tumor killing
- PCSK9 drives acquired resistance to anti-PD-1 immunotherapy through cystine metabolic reprogramming in lung cancer
- 基于心肌整体纵向应变和外周血中性粒细胞与淋巴细胞比值精准预测首发急性心肌梗死患者经皮冠状动脉介入治疗术后发生主要不良心血管事件风险：一项单中心前瞻性队列研究
- A Dissociation-Based Seahorse XF Workflow for Quantifying Averaged Bioenergetics in Anchorage-Independent Cancer Cell Clusters
- Exploring sex differences in global cancer incidence and mortality and the role of national development level
- Standardisation of stage information collected by European population-based cancer registries: an application to breast cancer survival
- Expression analysis of potential novel biomarkers TRIM29 alongside lncRNA NORAD and MIR497-HG in breast, gastric, and colorectal cancers
- Anti-PD-L1 antibody-coated metal-organic framework for targeted PTPN2 Inhibitor delivery and enhanced immunotherapy of head and neck squamous cell carcinoma
- Ascorbate is a physiological tumor suppressor metabolite in leukemia
- Temporal Dynamics of SMARCA4 Loss Define Its Role in Myogenic Differentiation of Alveolar Rhabdomyosarcoma
- Glycoconjugates tune the viscoelastic signature of mammary tumor progression
- Testis-Specific MAGEA3/6 Regulate Glycolysis to Promote Metabolic Flexibility and Reveal Therapeutic Vulnerabilities in Pancreatic Cancer Cells
- METTL1 gene dosage and catalytic activity define a targetable vulnerability in pediatric cancers